SOBRE ESTE EPISÓDIO
In this episode of The Connect Current, we sit down with Ben Shepherd, Ph.D., Co-founder and CEO of Trestle Bio, to explore how bioengineered kidney tissue could create new therapeutic possibilities for patients living with kidney failure. Ben shares how Trestle is working at the intersection of stem cell biology, kidney organoid science, 3D biofabrication, and regenerative medicine to build functional kidney tissue that could help restore renal function. The conversation dives into the patient need behind the company’s mission, what it takes to move ambitious science toward a real therapeutic product, and why San Diego continues to be a powerful place to build life science companies with meaningful patient impact.
Recorded at BioLabs San Diego:
https://www.biolabs.io/san-diego/
Learn more about Trestle Bio:
https://trestlebio.com/